MGI Investment Management
MGI Investment Management ApS was founded in 2024 and is 100% owned by Marigold Innovation ApS. MGI Investment Management specializes in investments within medical biotechnology. The projects offered by MGI Investment Management are carefully selected biotech projects from universities and other research institutions in Scandinavia. These projects undergo a thorough due diligence process at the universities or research institutions before MGI Investment Management decides whether to invest in them.
MGI Investment Management co-founds and invests in biotech companies alongside the researchers behind the projects. The focus is then on advancing these companies to a stage where they can be sold to, for example, big pharma companies, which will complete the development into a market-ready drug. MGI Investment Management ApS is registered as an alternative investment fund manager with the Danish Financial Supervisory Authority and is subject to AIFM legislation.
Investment Committee
The Investment Committee of MGI Investment Management approves and continuously monitors the investments on behalf of the fund. Collectively, the members have more than 140 years of industry experience in guiding investments toward high-growth and value-creating outcomes.
Peter Horn Møller
Founder & Charman of the Investment Committee
Benny Buchardt Andersen
Co-founder & Vice Charman of the Investment Committee
Jacob Ørndrup
Co-founder & Investment Committee Member
Charlotte Dyring
Investment Committee Member
Erik Vinther
Investment Committee Member
Partnerships
We collaborate with highly specialized partners in reporting, accounting, and compliance to ensure adherence to regulatory requirements.We are also collaborating with multiple organizations and companies in the biotech sector. The purpose is to leverage specialized expertise across various stages, from development to clinical trials and eventual exit to big pharma companies. This makes the process both more cost-effective and time-saving.
Ernst & Young (EY) is one of the world’s largest auditing and consulting firms, with 247,570 employees and operations in 150 countries. In 2008, the company had a global revenue of 24.5 billion USD, while its revenue in Denmark was 872 million DKK.
Embankment is a modern fund administrator and depositary that delivers advanced fund administration both digitally and efficiently. Today, Embankment services more than DKK 150 billion in investor assets and over 100 alternative investment funds across Scandinavia.
DLA Piper is one of the largest law firms in Denmark, employing nearly 200 lawyers in the country. DLA Piper provides legal advice to businesses and the public sector and has offices in over 40 countries with more than 4,500 lawyers worldwide.
Xplico performs valuations of companies and portfolios within biotech. Xplico is a market leader in this field, conducting over 100 biotech company valuations daily across the EU, USA, and Asia.
Potter Clarkson helps companies, organisations, and individuals across all sectors of business to identify, protect, exploit, and enforce the commercial value of their innovations anywhere in the world through intellectual property rights. The companies span from start-ups, SME’s, to global enterprises and VC’s.
Scantox is a premier preclinical research organization specializing in toxicology, pharmacology, and safety studies for the pharmaceutical and biotech industries. With state-of-the-art facilities and expert teams, Scantox delivers high-quality data to support drug development and regulatory approval processes.
CTC Clinical Trial Consultants is a full-service contract research organization providing expert clinical trial management and consulting services. Specializing in early-phase clinical trials, CTC supports pharmaceutical and biotech companies with efficient, high-quality trial execution to accelerate drug development.
CTR Center for Translational Research is dedicated to bridging the gap between laboratory discoveries and clinical applications. By focusing on translational medicine, CTR accelerates the development of innovative therapies, diagnostics, and medical technologies, helping to bring scientific advances to patients efficiently.
Fenwick provides specialized legal services tailored to life sciences companies, from startups to established firms. Their expertise covers intellectual property, regulatory compliance, M&A, and litigation, supporting clients at all stages of growth in the life sciences sector.
Interested in exploring the investment opportunities in Biotech?
Request introduction material here
About us
Registered AIFM
MGI Investment Management ApS is registered in the Danish Financial Supervisory Authority as an AIFM (Alternative Investment Fund Manager).
FTID: 23312
Auditor
Terms & Conditions
Ernst & Young
Authorised Auditor
CVR 30700228
© Marigold Innovation 2024